Janus Henderson Group’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$557K Hold
23,319
﹤0.01% 1893
2025
Q1
$581K Hold
23,319
﹤0.01% 1877
2024
Q4
$439K Hold
23,319
﹤0.01% 2094
2024
Q3
$351K Sell
23,319
-675,069
-97% -$10.2M ﹤0.01% 2191
2024
Q2
$20M Buy
698,388
+96,328
+16% +$2.76M 0.01% 570
2024
Q1
$17.6M Sell
602,060
-1,973
-0.3% -$57.7K 0.01% 582
2023
Q4
$20.4M Buy
604,033
+66,330
+12% +$2.24M 0.01% 547
2023
Q3
$16.5M Buy
537,703
+183,604
+52% +$5.63M 0.01% 571
2023
Q2
$14.2M Buy
354,099
+334,292
+1,688% +$13.4M 0.01% 622
2023
Q1
$808K Buy
19,807
+10,976
+124% +$448K ﹤0.01% 1745
2022
Q4
$341K Buy
8,831
+1
+0% +$39 ﹤0.01% 1917
2022
Q3
$470K Buy
8,830
+16
+0.2% +$852 ﹤0.01% 1982
2022
Q2
$514K Sell
8,814
-9
-0.1% -$525 ﹤0.01% 1746
2022
Q1
$674K Sell
8,823
-30,842
-78% -$2.36M ﹤0.01% 1722
2021
Q4
$2.39M Sell
39,665
-22,278
-36% -$1.34M ﹤0.01% 1220
2021
Q3
$3.47M Sell
61,943
-10,391
-14% -$582K ﹤0.01% 1142
2021
Q2
$4.39M Sell
72,334
-4,981
-6% -$302K ﹤0.01% 1089
2021
Q1
$5.42M Buy
+77,315
New +$5.42M ﹤0.01% 997
2016
Q1
Sell
-159,210
Closed -$12.2M 846
2015
Q4
$12.2M Buy
159,210
+25,708
+19% +$1.97M 0.1% 232
2015
Q3
$5.49M Buy
133,502
+25,990
+24% +$1.07M 0.05% 330
2015
Q2
$7.6M Buy
107,512
+9,612
+10% +$680K 0.06% 304
2015
Q1
$8.7M Buy
97,900
+32,430
+50% +$2.88M 0.07% 302
2014
Q4
$5.81M Buy
65,470
+11,578
+21% +$1.03M 0.04% 349
2014
Q3
$5.22M Buy
+53,892
New +$5.22M 0.05% 267